Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Asou, H.
Right arrow Articles by Koeffler, H. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Asou, H.
Right arrow Articles by Koeffler, H. P.
Related Collections
Right arrow Neoplasia
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Mechanisms of Growth Control of Kaposi's Sarcoma-Associated Herpes Virus-Associated Primary Effusion Lymphoma Cells

Hiroya Asou, Jonathan W. Said, Rong Yang, Reinhold Munker, Dorothy J. Park, Nanao Kamada, and H. Phillip Koeffler

From the Division of Hematology/Oncology and Pathology, Cedars-Sinai Medical Center, UCLA School of Medicine, Los Angeles, CA; and the Department of Cancer Cytogenetics, Division of Molecular Biology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.

Primary effusion lymphoma (PEL) is a distinct clinicopathologic entity associated with Kaposi's sarcoma-associated herpes virus (KSHV). Several cytokines, including interleukin-6 (IL-6), basic fibroblast growth factor (bFGF), and platelet-derived growth factor (PDGF) may be important for survival of KS cells. However, little is known about the interaction of cytokines with KSHV-infected lymphocytes from PEL. Therefore, we investigated what cytokines were produced by KSHV-infected PEL cell lines (KS-1, BC-1, BC-2), what cytokine receptors were expressed by these cells, what response these cells had to selected cytokines, and what was the effect of IL-6 antisense phosphorothioated oligonucleotides. Reverse transcriptase-polymerase chain reaction (RT-PCR) and protein studies showed that these three cell lines produced IL-10, IL-6, and the receptors for IL-6. The granulocyte macrophage colony-stimulating factor (GM-CSF), IL-1beta , IL-8, IL-12, bFGF, PDGF, and c-kit transcripts were not detected in the cell lines. High levels (0.7 to 5 ng/mL/106 cells/48 hours) of IL-6 protein were consistently detected in supernatants of the cell lines by enzyme-linked immunosorbent assay (ELISA) tests. In clonogenic assays, interferon-alpha (IFN-alpha ) and IFN-gamma suppressed the clonal growth of the PEL cells, but GM-CSF, IL-4, IL-6, IL-8, IL-10, and oncostatin M did not change it. We examined for several autocrine loops that have been suggested to occur in KS. Experiments using antisense oligonucleotides showed that the clonal growth of KS-1 and BC-1 was nearly 100% inhibited by IL-6 antisense oligonucleotides (10 µmol/L), but not at all by either oligonucleotides (<= 10 µmol/L) to IL-6 sense, IL-6 scrambled, viral IL-6 (vIL-6) antisense, or IL-10 antisense. Furthermore, the IL-6 antisense oligonucleotides had no effect on two B-cell lymphoma cell lines, which were not infected with KSHV. Addition of IL-6 antibody did not inhibit clonal growth of any of the cell lines. Taken together, we have defined the cytokines and their receptors expressed on PEL cells and have found that these cells synthesized IL-6 and IL-6 receptors; interruption of this pathway by IL-6 antisense oligonucleotides specifically prevented the growth of these cells. These findings will offer potential new therapeutic strategies for PEL.

Blood, Vol. 91 No. 7 (April 1), 1998: pp. 2475-2481
© 1998 by The American Society of Hematology.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Molecular Cancer TherapeuticsHome page
Y.-J. Zhang, R. S. Bonaparte, D. Patel, D. A. Stein, and P. L. Iversen
Blockade of viral interleukin-6 expression of Kaposi's sarcoma-associated herpesvirus
Mol. Cancer Ther., March 1, 2008; 7(3): 712 - 720.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S.-H. Sin, D. Roy, L. Wang, M. R. Staudt, F. D. Fakhari, D. D. Patel, D. Henry, W. J. Harrington Jr, B. A. Damania, and D. P. Dittmer
Rapamycin is efficacious against primary effusion lymphoma (PEL) cell lines in vivo by inhibiting autocrine signaling
Blood, March 1, 2007; 109(5): 2165 - 2173.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. M. Brinkmann, M. Pietrek, O. Dittrich-Breiholz, M. Kracht, and T. F. Schulz
Modulation of Host Gene Expression by the K15 Protein of Kaposi's Sarcoma-Associated Herpesvirus
J. Virol., January 1, 2007; 81(1): 42 - 58.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. T. Perry and T. Compton
Kaposi's Sarcoma-Associated Herpesvirus Virions Inhibit Interferon Responses Induced by Envelope Glycoprotein gpK8.1
J. Virol., November 15, 2006; 80(22): 11105 - 11114.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Arguello, S. Paz, E. Hernandez, C. Corriveau-Bourque, L. M. Fawaz, J. Hiscott, and R. Lin
Leukotriene A4 Hydrolase Expression in PEL Cells Is Regulated at the Transcriptional Level and Leads to Increased Leukotriene B4 Production.
J. Immunol., June 1, 2006; 176(11): 7051 - 7061.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. Xie, H. Pan, S. Yoo, and S.-J. Gao
Kaposi's Sarcoma-Associated Herpesvirus Induction of AP-1 and Interleukin 6 during Primary Infection Mediated by Multiple Mitogen-Activated Protein Kinase Pathways
J. Virol., December 15, 2005; 79(24): 15027 - 15037.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. M. Akula, P. W. Ford, A. G. Whitman, K. E. Hamden, B. A. Bryan, P. P. Cook, and J. A. McCubrey
B-Raf-dependent expression of vascular endothelial growth factor-A in Kaposi sarcoma-associated herpesvirus-infected human B cells
Blood, June 1, 2005; 105(11): 4516 - 4522.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
C. McCormick and D. Ganem
The Kaposin B Protein of KSHV Activates the p38/MK2 Pathway and Stabilizes Cytokine mRNAs
Science, February 4, 2005; 307(5710): 739 - 741.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
B. Glaunsinger and D. Ganem
Highly Selective Escape from KSHV-mediated Host mRNA Shutoff and Its Implications for Viral Pathogenesis
J. Exp. Med., August 2, 2004; 200(3): 391 - 398.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. An, Y. Sun, and M. B. Rettig
Transcriptional coactivation of c-Jun by the KSHV-encoded LANA
Blood, January 1, 2004; 103(1): 222 - 228.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
L. Duplomb, B. Chaigne-Delalande, P. Vusio, S. Raher, Y. Jacques, A. Godard, and F. Blanchard
Soluble Mannose 6-Phosphate/Insulin-Like Growth Factor II (IGF-II) Receptor Inhibits Interleukin-6-Type Cytokine-Dependent Proliferation by Neutralization of IGF-II
Endocrinology, December 1, 2003; 144(12): 5381 - 5389.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
U. Klein, A. Gloghini, G. Gaidano, A. Chadburn, E. Cesarman, R. Dalla-Favera, and A. Carbone
Gene expression profile analysis of AIDS-related primary effusion lymphoma (PEL) suggests a plasmablastic derivation and identifies PEL-specific transcripts
Blood, May 15, 2003; 101(10): 4115 - 4121.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. Cannon, N. J. Philpott, and E. Cesarman
The Kaposi's Sarcoma-Associated Herpesvirus G Protein-Coupled Receptor Has Broad Signaling Effects in Primary Effusion Lymphoma Cells
J. Virol., December 6, 2002; 77(1): 57 - 67.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
H. Deng, J. T. Chu, M. B. Rettig, O. Martinez-Maza, and R. Sun
Rta of the human herpesvirus 8/Kaposi sarcoma-associated herpesvirus up-regulates human interleukin-6 gene expression
Blood, August 13, 2002; 100(5): 1919 - 1921.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
H. Li and J. Nicholas
Identification of Amino Acid Residues of gp130 Signal Transducer and gp80 {alpha} Receptor Subunit That Are Involved in Ligand Binding and Signaling by Human Herpesvirus 8-Encoded Interleukin-6
J. Virol., May 3, 2002; 76(11): 5627 - 5636.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Gwack, S. Hwang, C. Lim, Y. S. Won, C. H. Lee, and J. Choe
Kaposi's Sarcoma-associated Herpesvirus Open Reading Frame 50 Stimulates the Transcriptional Activity of STAT3
J. Biol. Chem., February 15, 2002; 277(8): 6438 - 6442.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. An, A. K. Lichtenstein, G. Brent, and M. B. Rettig
The Kaposi sarcoma-associated herpesvirus (KSHV) induces cellular interleukin 6 expression: role of the KSHV latency-associated nuclear antigen and the AP1 response element
Blood, January 15, 2002; 99(2): 649 - 654.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
C. Liu, Y. Okruzhnov, H. Li, and J. Nicholas
Human Herpesvirus 8 (HHV-8)-Encoded Cytokines Induce Expression of and Autocrine Signaling by Vascular Endothelial Growth Factor (VEGF) in HHV-8-Infected Primary-Effusion Lymphoma Cell Lines and Mediate VEGF-Independent Antiapoptotic Effects
J. Virol., November 15, 2001; 75(22): 10933 - 10940.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
C. L. Perez and S. Rudoy
Anti-CD20 Monoclonal Antibody Treatment of Human Herpesvirus 8-Associated, Body Cavity-Based Lymphoma with an Unusual Phenotype in a Human Immunodeficiency Virus-Negative Patient
Clin. Vaccine Immunol., September 1, 2001; 8(5): 993 - 996.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
H. Li, H. Wang, and J. Nicholas
Detection of Direct Binding of Human Herpesvirus 8-Encoded Interleukin-6 (vIL-6) to both gp130 and IL-6 Receptor (IL-6R) and Identification of Amino Acid Residues of vIL-6 Important for IL-6R-Dependent and -Independent Signaling
J. Virol., April 1, 2001; 75(7): 3325 - 3334.
[Abstract] [Full Text]


Home page
Mol. Pathol.Home page
J Nicholas
Evolutionary aspects of oncogenic herpesviruses
Mol. Pathol., October 1, 2000; 53(5): 222 - 237.
[Abstract] [Full Text]


Home page
BloodHome page
Y. Aoki, R. Yarchoan, J. Braun, A. Iwamoto, and G. Tosato
Viral and cellular cytokines in AIDS-related malignant lymphomatous effusions
Blood, August 15, 2000; 96(4): 1599 - 1601.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
F. Pica, A. Volpi, A. Serafino, M. Fraschetti, O. Franzese, and E. Garaci
Autocrine nerve growth factor is essential for cell survival and viral maturation in HHV-8-infected primary effusion lymphoma cells
Blood, May 1, 2000; 95(9): 2905 - 2912.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. D. Jones, Y. Aoki, Y. Chang, P. S. Moore, R. Yarchoan, and G. Tosato
Involvement of Interleukin-10 (IL-10) and Viral IL-6 in the Spontaneous Growth of Kaposi's Sarcoma Herpesvirus-Associated Infected Primary Effusion Lymphoma Cells
Blood, October 15, 1999; 94(8): 2871 - 2879.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
X. Wan, H. Wang, and J. Nicholas
Human Herpesvirus 8 Interleukin-6 (vIL-6) Signals through gp130 but Has Structural and Receptor-Binding Properties Distinct from Those of Human IL-6
J. Virol., October 1, 1999; 73(10): 8268 - 8278.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y. Aoki, E. S. Jaffe, Y. Chang, K. Jones, J. Teruya-Feldstein, P. S. Moore, and G. Tosato
Angiogenesis and Hematopoiesis Induced by Kaposi's Sarcoma-Associated Herpesvirus-Encoded Interleukin-6
Blood, June 15, 1999; 93(12): 4034 - 4043.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
Sponsor: Genentech BioOncology and and Biogen Idec
Blood Online is supported in part by
Genentech BioOncology and Biogen Idec
  Copyright © 1998 by American Society of Hematology         Online ISSN: 1528-0020